Previous Article | Next Article ![]()
Infection and Immunity, August 2000, p. 4637-4646, Vol. 68, No. 8
Department of Biochemistry, Imperial College
of Science, Technology and Medicine, London SW7
2AZ,1 Department of Paediatric
Gastroenterology, St. Bartholomew's and the Royal London School of
Medicine and Dentistry, St. Bartholomew's Hospital, London EC1A
7BE,2 and University Department of
Paediatric Gastroenterology, Royal Free Hospital, London NW3
2QG,3 United Kingdom
Received 10 February 2000/Returned for modification 18 April
2000/Accepted 17 May 2000
The carboxy-terminal 280 amino acids (Int280) of the bacterial
adhesion molecule intimin include the receptor-binding
domain. At least five different types of Int280, designated Enteropathogenic Escherichia
coli (EPEC) is an important cause of severe infantile diarrheal
disease in many parts of the developing world. EPEC bacteria colonize
the small intestinal mucosa and, by subverting intestinal epithelial
cell function, produce a characteristic histopathological feature known
as the "attaching and effacing" (A/E) lesion (11). The
A/E lesion is characterized by localized destruction (effacement) of
brush border microvilli, intimate attachment of the bacillus to the
host cell membrane, and the formation of an underlying pedestal-like
structure in the host cell. Similar lesions have been associated with
several other bacterial mucosal pathogens, including
enterohemorrhagic E. coli (EHEC) (23) and
Citrobacter rodentium (28). EHEC is a food-borne pathogen of worldwide importance which can cause acute
gastroenteritis, hemorrhagic colitis, and hemolytic uremic syndrome
(23). C. rodentium is the causative
agent of transmissible murine colonic hyperplasia (3), a
disease of laboratory mice characterized by crypt hyperplasia,
epithelial cell proliferation, crypt dilation, mucosal thickening, and
the development of an uneven epithelial surface of the descending colon.
The first gene to be associated with A/E activity was eae,
which encodes the bacterial adhesion molecule intimin (16).
Mutational analysis of the eae genes of EPEC, EHEC, and
C. rodentium has shown that intimin is
necessary for colonization of the host and disease (7, 16,
29). Using human intestinal organ cultures as an infection model
system, intimin has been shown to be essential for colonization of the
mucosa and A/E lesion formation (13).
Recently, we and others described five distinct intimin subtypes,
intimin We and others have shown that Int280 (from EPEC, EHEC, and C. rodentium) can bind directly to uninfected host cells
(2, 8). However, intimin can also bind to the bacterial
receptor, Tir (EspE), which is translocated by the bacteria into the
host cell membrane during infection (5, 18). Recently, the
global fold of Int280 Oral infection of mice with live wild-type C. rodentium (15) or intracolonic inoculation of
dead bacteria (14) induces a CD3+ and
CD4+ T-cell infiltration into the colonic lamina
propria and a T-helper type 1 immune response. This response is
not observed, however, in mice inoculated with bacteria lacking
intimin, but is seen in mice inoculated with C. rodentium complemented with intimin Bacterial strains and plasmids.
The bacterial strains used
in this study were E. coli BL21 and TG1 and wild-type
C. rodentium, EPEC (strain E2348/69), and their
eae deletion mutants, strains DBS255 (28) and
CVD206 (6), respectively. The plasmids used in this study
are listed in Table 1. Plasmid pCVD438 is
a pACYC184 vector harboring the intimin
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Expression of Intimin
from Enterohemorrhagic
Escherichia coli in Citrobacter
rodentium

![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
,
,
,
, and
, have been described based on sequence variation in
this region. Importantly, the intimin types are associated with
different evolutionary branches and contribute to distinct
tissue tropism of intimin-positive bacterial pathogens. In this study
we engineered a strain of Citrobacter rodentium, which
normally displays intimin
, to express intimin
from
enterohemorrhagic Escherichia coli. We show that intimin
binds to the translocated intimin receptor (Tir) from C. rodentium and has the ability to produce attaching and effacing
lesions on HEp-2 cells. However, C. rodentium
expressing intimin
could not colonize orally infected mice or
induce mouse colonic hyperplasia. These results suggest that intimin
may contribute to host specificity, possibly through its interaction
with a receptor on the host cell surface.
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
,
,
,
, and
, based on sequence
variation within the C-terminal 280-amino-acid
receptor-binding domain of the polypeptide (Int280) (1,
25). Intimin
is specifically expressed by a group of EPEC
strains, all of which belong to one evolutionary branch of EPEC known
as EPEC clone 1 (32), and Hafnia alvei. Intimin
is mainly associated with EPEC and EHEC strains belonging to their
respective clones 2, C. rodentium and rabbit
diarrheagenic E. coli type 1, while intimin
is
associated with EHEC O157:H7 and EPEC O55:H7 (1).
This observation raises the possibility that tissue tropism exhibited
by EPEC (colonizing mainly the small bowel) and EHEC O157 (colonizing
the large bowel) is intimin related. Intimin exchange studies have been
performed in piglets using wild-type EHEC (expressing intimin
) or
EHEC expressing the EPEC-derived intimin
. In conventional animals,
no differences were seen in intestinal distribution of the A/E lesions
(7). However, in gnotobiotic piglets, EHEC expressing
intimin
produced A/E lesions in both the small and large intestines
whereas EHEC expressing intimin
produced lesions only in the large
intestine (30). More recently, we have shown, using human
intestinal explants, that EHEC O157:H7 expressing intimin
can
colonize and induce A/E lesion only on the follicle-associated
epithelium of the Peyer's patch (27). In
contrast, EPEC O127:H6 expressing intimin
(strain E2348/69)
colonized Peyer's patch as well as proximal and distal small
intestinal tissues (27). Importantly, tissue tropism towards Peyer's patches was observed following expression of intimin
in
the EPEC background (26). These results suggest that
different intimins may play a role in determining the pattern of
colonization and tissue tropism in the host.
in solution was determined by multidimensional nuclear magnetic resonance (17). The structure shows that
Int280 comprises three separate domains, two immunoglobulin-like
domains and a C-type lectin-like module. Modelling of other intimin
types shows that these proteins possess similar structures, which
define a new family of bacterial adhesion molecules.
from EPEC
encoded on pCVD438 (14, 15). In this study, we replaced the
receptor-binding domain of intimin
on pCVD438 with its intimin
homologue (generating plasmid pICC55). This hybrid intimin was
expressed in eae mutant strains of EPEC (CVD206)
(6) and C. rodentium (DBS255)
(28). Although biologically functional, this form of intimin
could not restore mouse virulence when expressed in DBS255. These
results suggest that the variable receptor-binding domain of intimin
may contribute to the species specificity exhibited by C. rodentium and by other A/E bacterial pathogens.
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
-encoding eae
gene from EPEC E2348/69 (6). pCVD444 is a pUC18 vector
harboring the intimin
-encoding eae gene from EHEC EDL933 (33). Bacteria were grown at 37°C in L broth or
Dulbecco's modified Eagle's medium. Where appropriate,
chloramphenicol and ampicillin were added to final concentrations of 30 and 100 µg/ml, respectively.
TABLE 1.
Plasmids used in this study
Construction of hybrid intimin
and maltose-binding
protein (MBP)-Int280
fusion protein.
A schematic
representation of the strategy used to produce the hybrid intimin
is shown in Fig. 1. In order to replace
the receptor-binding domain of intimin
in pCVD438 with the intimin
homologue, we took advantage of two unique restriction endonuclease sites located in pCVD438, a conserved SalI site located
upstream of the receptor binding domain (position 1663 of the
eae gene) and an EagI site located downstream to
the TAA stop codon and within the pACYC184 vector plasmid
(9). The DNA fragment between the SalI site and
the 3' end of the eae gene encoding intimin
from pCVD444
was amplified by PCR using a forward primer (1606-5' GGC AAT AGC TCT
AAC AAT GTA) and an eae
-derived reverse primer overlapping the 3' end of the gene and including an EagI
restriction endonuclease site (5' CTT ACA TGR AGC ATC AGC ATA ATA GGC
TTG), as previously described (8). The amplified
eae fragment, flanked by SalI and EagI
restriction sites, was used to replace the corresponding fragments of
pCVD438 as previously described (9) (Fig. 1). Following
confirmation by DNA sequencing, the modified plasmid, pICC55 (Table 1),
was transformed into the eae deletion mutants of EPEC and
C. rodentium, strains CVD206 and DBS255,
respectively, by electroporation.
|
was induced by
IPTG (isopropyl-
-D-thiogalactopyranoside), and the
fusion protein was purified as previously described (8).
Detection of intimin expression by Western blotting and FAS. Expression of the intimin derivatives was determined by Western blotting (4). Briefly, stationary L broth cultures were diluted 1:100 in Dulbecco's modified Eagle's medium and incubated for 3 h at 37°C. An equivalent of a culture at an optical density at 600 nm (OD600) of 0.5 was loaded onto sodium dodecyl sulfate-7.5% polyacrylamide gel electrophoresis (SDS-7.5% PAGE) as described (4). The electrophoresed polypeptides were transferred to a nitrocellulose membrane, and immunodetection of intimin was performed using a universal intimin antiserum raised in rabbits against a conserved intimin fragment (amino acids Gly388 to Lys667) (4) diluted 1:500. Fluorescence actin staining (FAS) test was employed for 3 and 6 h to detect A/E lesion formation on HEp-2 cells as described previously (20, 24).
Preparation of C. rodentium His-Tir and gel overlays. The DNA segment encoding Tir in C. rodentium (Tir-Cr) was amplified using C. rodentium DNA as template (primers: forward, 5'-GAAGATCTATGCCTATTGGTAATCTTGGT; reverse, 5'-GAAGATCTTTAGACGAAACGATGGGATC). The tir fragment was sequenced and cloned into the BamHI site of pET28a (generating plasmid pICC56) in E. coli BL21 previously described (12). For gel overlays, whole-bacterial-cell protein extract from E. coli BL21a(pICC56) expressing Tir-Cr was separated by SDS-PAGE, blotted onto a nitrocellulose membrane as described above, and blocked with 10% skim milk in phosphate-buffered saline (PBS)-0.1% Tween 20 overnight. The nitrocellulose membranes were reacted with either rabbit anti-Tir antibodies (12) or with 5 µg of the purified MBP-Int280 fusion proteins per ml in PBS-0.1% Tween 20 for 2 h and washed twice for 5 min in PBS-0.1% Tween 20. Binding of MBP fusions or Tir antibodies to Tir-Cr was detected with rabbit anti-MBP antiserum (1:2,000 for 1 h) and/or anti-rabbit antibodies conjugated to alkaline phosphatase (1:2,000 for 1 h) (12).
IVOC adhesion assay. Tissue was obtained, with fully informed parental consent and ethics approval, using grasp biopsy forceps during routine endoscopic (Olympus PCF pediatric endoscope) investigation of intestinal disorders. Terminal ileal Peyer's patch tissue was taken from patients from areas showing no endoscopic abnormality. IVOC infection was performed as described previously (13). The assay was terminated at 8 h. Each bacterial strain was examined in in vitro organ cultures (IVOC) on least three occasions by using tissue from different children.
Challenge of mice with C. rodentium.
Mice
(Swiss NIH, C3H) were orally inoculated by gavage with C. rodentium, DBS255(pCVD438), DBS255(pICC55), and
DBS255. Bacteria were diluted with PBS (pH 7.2) to an OD600
of 1.7 and delivered to mice in a volume of 100 µl as previously
described (15). Mice were killed at 12 days postchallenge,
and tissue was snap frozen in liquid nitrogen and stored at
70°C
for further analysis.
Immunohistochemistry. Three-step avidin-peroxidase staining was performed on 5-mm-diameter frozen sections as described previously (15) using monoclonal antibodies 145-2C11 (anti-CD3) and YTS 191 (anti-CD4). Biotin-conjugated rabbit anti-rat immunoglobulin G (IgG) (DAKO, High Wycombe, United Kingdom) and goat anti-hamster IgG (Vector Laboratories, Peterborough, United Kingdom) were used at a 1:50 dilution in Tris-buffered saline (TBS) (pH 7.6) containing 4% (vol/vol) normal mouse serum (Harlan Seralab, Oxon, United Kingdom). Avidin peroxidase (Sigma) was used at a dilution of 1:200 in TBS. A two-step protocol was performed using rabbit anti-intimin antibody (4) together with horseradish peroxidase-conjugated swine anti-rabbit IgG secondary antibody. Peroxidase activity was detected with 3,3'-diaminobenzidine-tetra-hydrochloride (DAB; Sigma) in 0.5 mg of Tris-HCl (pH 7.6) per ml containing 0.01% H2O2. Endogenous-peroxidase-containing cells were visualized by incubation of sections with DAB substrate and H2O2 alone. The density of positive cells in the lamina propria was determined by image analysis as described previously (15).
Inoculation of dead bacteria and analysis of hyperplasia and cellular infiltrate. Formalin-killed bacteria (5 × 108) were injected into the colon of BALB/c mice treated 15 min previously with 0.1 ml of 50% ethanol to break the mucosal barrier (14). Six days later, mice were killed and the colon was dissected out. The weight of the terminal 4 cm of distal colon was determined, and then the sample was immediately snap frozen in liquid nitrogen for immunohistochemistry. Mucosal thickness (i.e., crypt length) was measured on well-oriented sections of colon by using a calibrated eyepiece graticule as described previously (14). At least five measurements were made per sample, and there were five mice per group. The densities of CD3, CD4, and CD8+ cells in the lamina propria were analyzed using a Seescan image analyzer as previously described (15).
| |
RESULTS |
|---|
|
|
|---|
Construction of hybrid intimin
.
We have shown previously
that wild-type C. rodentium (expressing intimin
)
and C. rodentium expressing the EPEC-derived
intimin-
[DBS255(pCVD438)] colonize and produce A/E lesions
only in the descending colon of orally challenged mice (10).
In order to investigate the tissue selectivity exhibited by C. rodentium expressing intimin
, we expressed this
intimin in DBS255 from the high-copy-number, pUC18-derived
plasmid pCVD444 (33). A cat cassette
(pCVD444*) was inserted into this vector to overcome the natural
ampicillin resistance of C. rodentium (data not
shown). Only low levels of intimin were detected in whole-cell extracts
of DBS255(pCVD444*) (data not shown). In order to circumvent poor
expression, we replaced the receptor-binding domain of intimin
on
pCVD438, which was already shown to mediate high levels of intimin
expression on the cell surface of DBS255, with that of intimin
(see
Materials and Methods and Fig. 1) to produce a plasmid, pICC55. Since
the amino-terminal 554 amino acids of intimin
encoded by the
recombinant eae gene on pICC55 are 97% identical to the
homologous region of intimin
(Fig. 1), the hybrid intimin is, for
all intents and purposes, intimin
. The hybrid intimin
was
expressed in DBS255(pICC55) and CVD206(pICC55), and its
biological activity was tested. The isogenic strains
DBS255(pCVD438) and CVD206(pCVD438) were used as controls.
is expressed in DBS255 at a level comparable to
that of intimin
and to those of the recombinant CVD206 strains.
|
Interaction of CVD206 expressing the hybrid intimin
with HEp-2
cells and human intestinal IVOC.
Before the recombinant DBS255
strain was tested in the mouse model, the hybrid intimin
was
subjected to a number of in vitro biological assays, using
CVD206(pICC55), designed to determine the influence of
the genetic manipulation on the function of this construct. Firstly,
the ability of the hybrid intimin
to mediate A/E lesion
formation on HEp-2 cells was investigated. CVD206(pICC55) adhered to cell monolayers in a localized pattern and produced a
FAS-positive reaction, similar to that of CVD206(pCVD438)
(data not shown). The result shows that this intimin
can
mediate A/E lesion formation on cultured human epithelial cells.
to mediate A/E lesion formation on mucosal surfaces, healthy human tissue obtained from terminal ileal
Peyer's patch of children was examined after infection with CVD206(pICC55). Like CVD206(pCVD438), CVD206(pICC55)
was able to form A/E lesions on the human tissue (three out of
three incubations) (Fig. 3). No binding
was observed with CVD206 only (data not shown and reference
12). These results show that pICC55 encodes a biologically functional intimin that can mediate binding and A/E lesion on mucosal surfaces.
|
Colonization of the mouse intestine following live oral infections
with C. rodentium.
Following verification of the
binding activity of the hybrid intimin
in EPEC, we confirmed its
ability to restore A/E lesion formation on HEp-2 cells to DBS255
and tested mouse virulence of DBS255(pICC55). To test the
ability of DBS255(pICC55) to mediate A/E lesion formation on
HEp-2 cells, monolayers were infected with DBS255(pCVD438) or
DBS255(pICC55) cells for 6 h as previously described
(24). Both DBS255(pCVD438) and DBS255(pICC55) cells adhered poorly to HEp-2 cell monolayers, but FAS-positive bacteria were
observed for both strains (Fig. 4).
|
|
|
The hybrid intimin
binds Tir from C. rodentium.
The fact that the hybrid intimin
confers
A/E lesion formation activity to DBS255(pICC55) on HEp-2 cells
indicates that it binds Tir from C. rodentium
(Tir-Cr). In order to confirm this experimentally, gel
overlay binding assays were used to probe for the interaction of
the hybrid intimin
with Tir-Cr. For this purpose, the DNA fragment
encoding Tir-Cr was amplified by PCR and cloned into the
expression vector pET28a (generating plasmid pICC56) in E. coli BL21. Partial sequencing of the N- and C-terminal regions of
Tir-Cr revealed exact homology with a Tir sequence derived from mouse
enteropathogenic E. coli (MPEC) (accession no. AB 026719)
(22). In parallel, the DNA fragment encoding the
carboxy-terminal 280-amino-acid receptor-binding domain of the
hybrid intimin
(Int280
) was amplified by PCR and cloned into
pMAL-c vector (generating plasmid pICC58) in E. coli TG1. Int280
was overexpressed and purified as an MBP fusion
(MBP-Int280
). MBP-Int280
and MBP were used as positive and
negative controls, respectively.
or MBP-Int280
fusion proteins or
MBP or with anti-Tir antiserum (12). Binding of the intimin
derivatives was detected following further incubations with rabbit
anti-MBP and/or alkaline phosphatase-conjugated anti-rabbit antisera. These overlay experiments, although they did not provide a
quantitative measure, showed that similarly to anti-Tir antibodies, both Int280
and the hybrid Int280
could bind Tir-Cr (Fig.
7). No binding was detected using MBP
only (data not shown).
|
Mouse colonic hyperplasia and T-cell infiltration.
In a
previous study, we showed that intracolonic inoculation of mice with
dead C. rodentium expressing either intimin
or intimin
induced T-cell infiltration to the lamina propria at the
base of the crypts and colonic inflammation and hyperplasia without
detectable bacterial colonization. To test for the Tir-independent biological function of the hybrid intimin
in vivo, we investigated T-cell infiltration of the colonic submucosa following inoculation with
dead DBS255(pICC55) bacteria. In contrast to inoculation with
wild-type and intimin
-expressing C. rodentium,
no T-cell infiltration or increases in colonic weight or mucosal
thickness were detected following infection with C. rodentium expressing the hybrid intimin
or DBS255
(Fig. 8). Taken together, these results
show that the hybrid intimin
cannot restore mouse virulence to
C. rodentium and, unlike intimin
and
, it has
no biological activity in the murine situation.
|
| |
DISCUSSION |
|---|
|
|
|---|
Intimin was the first gene product of EPEC to be associated with
A/E lesion formation (16). Recently, the eae
genes from different A/E lesion forming bacterial pathogens were
categorized into a family of antigenically distinct intimin types (
,
,
,
,
) (1, 25). Studies on the different
intimins from EPEC, EHEC, and C. rodentium have
shown that receptor-binding activity is localized to the C-terminal 280 amino acids (Int280) (8). A number of groups have reported
that intimin can bind directly to uninfected host cells (2,
8) and to a receptor encoded by the bacteria, termed Tir, which
is translocated into the host cell membrane via a type III secretion
system (18). Binding to the host cell but not to Tir is
dependent on a disulfide bridge at the carboxy terminus of
Int280 (12). However, when expressed on the surface of EPEC,
both of these binding activities of intimin are required for intimate
bacterial adhesion and A/E lesion formation.
Recently, the global fold of Int280
in solution was determined by
multidimensional nuclear magnetic resonance (17). The structure shows that Int280 is built from three globular domains: D1
(residues 1 to 91), D2 (residues 93 to 181), and D3 (residues 183 to
280). The first two domains, D1 and D2, although lacking disulfide
bonds, resemble the type I set of the Ig super family (IgSF). The IgSF
domains in intimin appear to form an articulated linker that most
likely extends away from the bacterium surface and confers a highly
accessible third domain, D3 (residues 183 to 280), for potential
interaction. Despite the lack of significant sequence homology, the
topology in Int280 D3 is reminiscent of C-type lectins, a family of
proteins responsible for cell surface carbohydrate recognition. These
findings imply that carbohydrate recognition may be important for
intimin-mediated cell adhesion, which in turn may provide a mechanism
for tissue tropism exhibited by different A/E lesion
forming bacterial pathogens. Indeed, a recent study by
Vanmaele et al. (31) showed that coincubation of
EPEC with Lewis X-bovine serum albumin glycoconjugate caused a decrease
in intimin expression by the bacteria. These results are consistent
with our previous observations of down regulation of intimin expression
following A/E lesion formation (19).
Intimin exchange studies performed in piglets suggest that different
intimin types might determine tissue tropism. In these studies,
wild-type EHEC bacteria (expressing intimin
) or EHEC bacteria
expressing the EPEC-derived intimin
were used. In conventional animals (7), no differences were seen in the intestinal
distribution of the A/E lesions, but in gnotobiotic piglets
(30), EHEC expressing intimin
produced A/E lesions
in both the small and large intestines whereas EHEC expressing intimin
produced lesions only in the large intestine. More recently we have
shown that intimin contributes to tissue tropism exhibited by EPEC
(colonizing all regions of human small intestinal explants) and EHEC
(which specifically target the follicle-associated epithelium of the
Peyer's patch) (26, 27). The aim of the present study was
to extend these investigations further to study the contribution of the
intimin types to host (species) specificity.
A difficulty associated with working on EPEC and EHEC is the lack of a
small animal model for studying the biological properties of
EPEC-associated genes in an in vivo situation. C. rodentium causes transmissible colonic hyperplasia in mice
(3), an infection associated with the formation of A/E
lesions similar to those described for human EPEC (28).
C. rodentium has been shown to harbor the loss of
enterocyte effacement pathogenicity island encoding an eae
homologue (21) that directs the expression of an intimin
protein that is essential for A/E lesion formation and infection of
mice (29). Moreover, expression of intimin
from EPEC
restores the ability of DBS255 to colonize the colon of orally
challenged mice (10). This model provides an opportunity to
evaluate the in vivo biological functions of different intimin types in mice.
In the present study, we determined the outcome of mouse inoculation
with DBS255 bacteria expressing intimin
. Since low intimin
expression was observed in DBS255 bacteria expressing intimin
from a pUC18-cloned eae gene (pCVD444*), we generated a hybrid intimin
based on pCVD438 expressing intimin
. This intimin contains the receptor-binding domain of intimin
, presented on a cloned intimin
backbone which itself is 97% identical to intimin
. This clone of intimin
has already been shown to
mediate efficient intimin expression and to restore mouse virulence to DBS255.
Before using the recombinant eae gene in the C. rodentium mouse model, we confirmed that it encodes a
biologically active intimin. This was achieved by expressing the hybrid
intimin
in CVD206(pICC55) bacteria. The hybrid intimin
was produced in CVD206(pICC55) bacteria at a level similar to
that of intimin
in CVD206(pCVD438) bacteria. CVD206(pICC55)
bacteria adhered and induced A/E lesions on HEp-2
cells. Importantly, this strain colonized and induced
A/E lesions on human intestinal IVOC. Following these bioassays, we
expressed the hybrid intimin
in DBS255 cells. Using live
DBS255(pICC55) bacteria to infect HEp-2 cells, we showed that the strain is capable of inducing A/E lesions and hence
the hybrid intimin
is biologically functional in the C. rodentium background and can cooperate with the other
virulence factors involved in this process. The ability of the hybrid
intimin
to bind Tir-Cr was demonstrated using gel overlays and
recombinant proteins. In contrast, mice oral challenges revealed that,
unlike intimin
, intimin
could not restore mouse virulence to
DBS255 bacteria. This suggests intimin
may exhibit a host
cell-encoded receptor binding specificity or affinity that differs from
intimin
or intimin
and that this receptor is not
expressed, at least at a sufficient level, in the mouse gut. This
result is consistent with our data showing different tissue tropism
between CVD206 expressing
and CVD206 expressing intimin
,
using IVOC from different regions of the human gut (26).
In previous studies, we have shown that following intracolonic
inoculation of formalin-killed C. rodentium cells
expressing either intimin
or intimin
there was an extensive,
Tir-independent, infiltration of CD3+ CD4+ T
cells even though no bacteria were seen in association with the mucosa.
For this reason, we have examined the distal colon of mice inoculated
with DBS255(pICC55) cells expressing the hybrid intimin
for
signs of T-cell infiltration. None of the mice inoculated with intimin
-encoding bacteria showed evidence of T-cell infiltration or colonic
hyperplasia. These data provide further evidence that intimin
does
not bind to the mouse gut and supports the role of a host cell intimin
receptor in colonization and disease. However, intimin is unlikely to
be the only factor that determines host specificity, as although
C. rodentium expressing intimin
causes colonic
hyperplasia, as does intimin
when presented to permeabilized rectum on dead EPEC E2348/69 and CVD206(pCVD438) cells, these latter strains cannot colonize mouse colon or induce A/E lesions following live oral challenge. Accordingly, it seems that, like many
other virulence properties, host specificity is a multifactorial and
multigenic property of C. rodentium and EPEC.
| |
ACKNOWLEDGMENTS |
|---|
We thank Jim Kaper for providing bacterial strains and plasmid pCVD444, Michael Donnenberg for plasmid pCVD438, and David Schauer for DBS255. We thank Anton Page for his help with the photography.
E.L.H. is the recipient of a Royal Society/NHMRC Howard Florey Fellowship. This work was supported by a grant from the BBSRC.
E.L.H. and V.H. contributed equally to this paper.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Biochemistry, Imperial College, London SW7 2AZ, United Kingdom. Phone: 44-20-7594-5253. Fax: 44-20-7594-5255. E-mail: g.frankel{at}ic.ac.uk.
Present address: Institute of Microbiology and Genetics, University
of Vienna, A-1030 Vienna, Austria.
Editor: D. L. Burns
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Adu-Bobie, J.,
G. Frankel,
C. Bain,
A. G. Goncaleves,
L. R. Trabulsi,
G. Douce,
S. Knutton, and G. Dougan.
1998.
Detection of intimin , , , and , four intimin derivatives expressed by attaching and effacing microbial pathogens.
J. Clin. Microbiol.
36:662-668 |
| 2. | An, H., J. M. Fairbrother, J. D. Dubreuil, and J. Harel. 1997. Cloning and characterization of the eae gene from a dog attaching and effacing Escherichia coli strain 4221. FEMS Microbiol. Lett. 148:239-245[CrossRef][Medline]. |
| 3. | Barthold, S. W., G. L. Coleman, R. O. Jacoby, E. M. Livstone, and A. M. Jonas. 1976. Transmissiable murine colonic hyperplasia. Vet. Pathol. 15:223-236. |
| 4. |
Batchelor, M.,
S. Knutton,
A. Caprioli,
V. Huter,
M. Zanial,
G. Dougan, and G. Frankel.
1999.
Development of a universal intimin antiserum and PCR primers.
J. Clin. Microbiol.
37:3822-3827 |
| 5. | Deibel, C., S. Kramer, T. Chakraborty, and F. Ebel. 1998. EspE, a novel secreted protein of attaching and effacing bacteria, is directly translocated into infected host cells, where it appears as a tyrosine-phosphorylated 90 kDa protein. Mol. Microbiol. 28:463-474[CrossRef][Medline]. |
| 6. |
Donnenberg, M. S., and J. B. Kaper.
1991.
Construction of an eae deletion mutant of enteropathogenic Escherichia coli by using a positive-selection suicide vector.
Infect. Immun.
59:4310-4317 |
| 7. | Donnenberg, M. S., S. Tzipori, M. L. McKee, A. D. O'Brien, J. Alroy, and J. B. Kaper. 1993. The role of the eae gene of enterohemorrhagic Escherichia coli in intimate attachment in vitro and in a porcine model. J. Clin. Investig. 92:1418-1424. |
| 8. |
Frankel, G.,
D. C. A. Candy,
P. Everest, and G. Dougan.
1994.
Characterization of the C-terminal domains of intimin-like proteins of enteropathogenic and enterohemorrhagic Escherichia coli, Citrobacter freundii, and Hafnia alvei.
Infect. Immun.
62:1835-1842 |
| 9. | Frankel, G., A. D. Philips, M. Novakova, M. Batchelor, S. Hicks, and G. Dougan. 1998. Generation of Escherichia coli intimin-derivatives with differing biological activities using site-directed mutagenesis of the intimin C-terminus domain. Mol. Microbiol. 29:559-570[CrossRef][Medline]. |
| 10. | Frankel, G., A. D. Phillips, M. Novakova, H. Field, D. C. A. Candy, D. B. Schauer, G. Douce, and G. Dougan. 1996. Intimin from enteropathogenic Escherichia coli restores murine virulence to a Citrobacter rodentium eaeA mutant: induction of an immunoglobulin A response to intimin and EspB. Infect. Immun. 64:5315-5325[Abstract]. |
| 11. | Frankel, G., A. D. Phillips, I. Rosenshine, G. Dougan, J. B. Kaper, and S. Knutton. 1998. Enteropathogenic and enterohaemorrhagic Escherichia coli: more subversive elements. Mol. Microbiol. 30:911-921[CrossRef][Medline]. |
| 12. | Hartland, E. L., M. Batchelor, R. M. Delahay, C. Hale, S. Matthews, G. Dougan, S. Knutton, I. Connerton, and G. Frankel. 1999. Binding of intimin from enteropathogenic Escherichia coli to Tir and to host cells. Mol. Microbiol. 32:151-158[CrossRef][Medline]. |
| 13. |
Hicks, S.,
G. Frankel,
J. B. Kaper,
G. Dougan, and A. D. Phillips.
1998.
Role of intimin and bundle-forming pili in enteropathgenic Escherichia coli adhesion to pediatric intestinal tissue in vitro.
Infect. Immun.
66:1570-1578 |
| 14. |
Higgins, L. M.,
G. Frankel,
I. Connerton,
N. S. Goncalves,
G. Dougan, and T. T. MacDonald.
1999.
Role of bacterial intimin in colonic hyperplasia and inflammation.
Science
285:588-591 |
| 15. |
Higgins, L. M.,
G. Frankel,
G. Douce,
G. Dougan, and T. T. MacDonald.
1999.
Citrobacter rodentium infection in mice elicits a mucosal Th1 cytokine response and lesions similar to those in murine inflammatory bowel disease.
Infect. Immun.
67:3031-3139 |
| 16. |
Jerse, A. E.,
J. Yu,
B. D. Tall, and J. B. Kaper.
1990.
A genetic locus of enteropathogenic Escherichia coli necessary for the production of attaching and effacing lesions on tissue culture cells.
Proc. Natl. Acad. Sci. USA
87:7839-7843 |
| 17. | Kelly, G., S. Prasannan, S. Daniell, K. Fleming, G. Frankel, G. Dougan, I. Connerton, and S. Matthews. 1999. Structure of the cell-adhesion fragment of intimin from enteropathogenic Escherichia coli. Nat. Struct. Biol. 6:313-318[CrossRef][Medline]. |
| 18. | Kenny, B., R. DeVinney, M. Stein, D. J. Reinscheid, E. A. Frey, and B. B. Finlay. 1997. Enteropathogenic E. coli (EPEC) transfers its receptor for intimate adherence into mammalian cells. Cell 91:511-520[CrossRef][Medline]. |
| 19. | Knutton, S., J. Adu-Bobie, C. Bain, A. D. Phillips, G. Dougan, and G. Frankel. 1997. Down regulation of intimin expression during attaching and effacing enteropathogenic Escherichia coli adhesion. Infect. Immun. 65:1644-1652[Abstract]. |
| 20. |
Knutton, S.,
T. Baldwin,
P. H. Williams, and A. S. McNeish.
1989.
Actin accumulation at sites of bacterial adhesion to tissue culture cells: basis of a new diagnostic test for enteropathogenic and enterohemorrhagic Escherichia coli.
Infect. Immun.
57:1290-1298 |
| 21. |
McDaniel, T. K.,
K. G. Jarvis,
M. S. Donnenberg, and J. B. Kaper.
1995.
A genetic locus of enterocyte effacement conserved among diverse enterobacterial pathogens.
Proc. Natl. Acad. Sci. USA
92:1664-1668 |
| 22. | Nakagawa, M., R. Sakazaki, T. Muto, M. Saito, T. Hagiwara, and K. Imaizumi. 1996. Infectious megaenteron of mice. II. Detection of coliform organisms of an unusual biotype as the primary cause. Jpn. J. Med. Sci. Biol. 22:357-382. |
| 23. |
Nataro, J. P., and J. B. Kaper.
1998.
Diarrheagenic Escherichia coli.
Clin. Microbiol. Rev.
11:142-201 |
| 24. |
Newman, J. V.,
B. A. Zabel,
S. S. Jha, and D. B. Schauer.
1999.
Citrobacter rodentium espB is necessary for signal transduction and for infection of laboratory mice.
Infect. Immun.
67:6019-6025 |
| 25. |
Oswald, E.,
H. Schmidt,
S. Morabito,
H. Karch,
O. Marches, and A. Caprioli.
2000.
Typing of intimin genes in human and animal enterohemorrhagic and enteropathogenic Escherichia coli: characterization of a new intimin variant.
Infect. Immun.
68:64-71 |
| 26. | Phillips, A. D., and G. Frankel. 2000. Intimin-mediated tissue specificity in enteropathogenic Escherichia coli interaction with human intestinal organ cultures. J. Infect. Dis. 181:1496-1500[CrossRef][Medline]. |
| 27. | Phillips, A. D., S. Navabpor, S. Hicks, G. Dougan, T. Wallis, and G. Frankel. 2000. Enterohaemorrhagic Escherichia coli O157:H7 targets Peyer's patches in man and causes attaching-effacing lesions in both human and bovine intestine. Gut, in press. |
| 28. |
Schauer, D. B., and S. Falkow.
1993.
Attaching and effacing locus of a Citrobacter freundii biotype that causes transmissible murine colonic hyperplasia.
Infect. Immun.
61:2486-2492 |
| 29. |
Schauer, D. B., and S. Falkow.
1993.
The eae gene of Citrobacter freundii biotype 4280 is necessary for colonization in transmissible murine colonic hyperplasia.
Infect. Immun.
61:4654-4661 |
| 30. | Tzipori, S., F. Gunzer, M. S. Donnenberg, L. de Montigny, J. B. Kaper, and A. Donohue-Rolfe. 1995. The role of the eaeA gene in diarrhea and neurological complications in a gnotobiotic piglet model of enterohemorrhagic Escherichia coli infection. Infect. Immun. 63:3621-3627[Abstract]. |
| 31. |
Vanmaele, R. P.,
L. D. Heerze, and G. D. Armstrong.
1999.
Role of lactosyl glycan sequences in inhibiting enteropathogenic Escherichia coli attachment.
Infect. Immun.
67:3302-3307 |
| 32. | Whittam, T. S., and E. A. McGraw. 1996. Clonal analysis of EPEC serogroups. Rev. Microbiol. (Sao Paulo) 27(Suppl. 1):7-16. |
| 33. | Yu, J., and J. B. Kaper. 1992. Cloning and characterization of the eae gene of enterohaemorrhagic Escherichia coli O157:H7. Mol. Microbiol. 6:411-417[CrossRef][Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»